299 related articles for article (PubMed ID: 27034168)
1. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Chen Y; Han Q; Lv Y; Liu Z
Medicine (Baltimore); 2016 Dec; 95(52):e5749. PubMed ID: 28033288
[TBL] [Abstract][Full Text] [Related]
3. Genetic association and interaction of PD1 and TIM3 polymorphisms in susceptibility of chronic hepatitis B virus infection and hepatocarcinogenesis.
Li F; Fan X; Wang X; Deng H; Zhang X; Zhang K; Li N; Han Q; Lv Y; Liu Z
Discov Med; 2019 Feb; 27(147):79-92. PubMed ID: 30939292
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.
Li Z; Li N; Zhu Q; Zhang G; Han Q; Zhang P; Xun M; Wang Y; Zeng X; Yang C; Liu Z
Infect Genet Evol; 2013 Mar; 14():240-6. PubMed ID: 23291409
[TBL] [Abstract][Full Text] [Related]
5. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
6. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study.
Yamamoto M; Kobayashi T; Mashima H; Miki D; Kuroda S; Hamaoka M; Aikata H; Chayama K; Ohdan H
Int J Surg; 2020 Aug; 80():84-90. PubMed ID: 32615319
[TBL] [Abstract][Full Text] [Related]
7. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
[TBL] [Abstract][Full Text] [Related]
9. Association of T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) polymorphisms with susceptibility and disease progression of HBV infection.
Liao J; Zhang Q; Liao Y; Cai B; Chen J; Li L; Wang L
PLoS One; 2014; 9(5):e98280. PubMed ID: 24867713
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
11. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
13. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract][Full Text] [Related]
14. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.
Zhang G; Li N; Zhang P; Li F; Yang C; Zhu Q; Han Q; Lv Y; Zhou Z; Liu Z
Immunol Lett; 2014 Nov; 162(1 Pt A):212-6. PubMed ID: 25218665
[TBL] [Abstract][Full Text] [Related]
15. Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma.
Zhu Q; Li N; Li F; Sang J; Deng H; Han Q; Lv Y; Li C; Liu Z
Int Immunopharmacol; 2017 Aug; 49():126-131. PubMed ID: 28575727
[TBL] [Abstract][Full Text] [Related]
16. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma.
Li G; Zheng Z
Tumour Biol; 2013 Jun; 34(3):1589-94. PubMed ID: 23404408
[TBL] [Abstract][Full Text] [Related]
18. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
[TBL] [Abstract][Full Text] [Related]
19. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
